- All sections
- G - Physics
- G16B - Bioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology
- G16B 15/30 - Drug targeting using structural data; Docking or binding prediction
Patent holdings for IPC class G16B 15/30
Total number of patents in this class: 537
10-year publication summary
1
|
7
|
4
|
7
|
37
|
38
|
64
|
123
|
163
|
43
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Genentech, Inc. | 3742 |
18 |
NEC Laboratories America, Inc. | 995 |
17 |
DeepMind Technologies Limited | 788 |
14 |
Tencent Technology (Shenzhen) Company Limited | 12951 |
8 |
Flagship Pioneering Innovations VI, LLC. | 288 |
8 |
Pythia Labs, Inc. | 8 |
8 |
X Development LLC | 1453 |
7 |
Fujitsu Limited | 19265 |
6 |
The Broad Institute, Inc. | 1584 |
6 |
Regeneron Pharmaceuticals, Inc. | 3650 |
6 |
NEC Oncoimmunity AS | 14 |
6 |
The Regents of the University of California | 18943 |
5 |
International Business Machines Corporation | 60644 |
5 |
FUJIFILM Corporation | 27102 |
5 |
Massachusetts Institute of Technology | 9795 |
5 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
5 |
Ecole Polytechnique Federale de Lausanne (epfl) | 1434 |
5 |
Cyclica Inc. | 12 |
5 |
Benevolentai Technology Limited | 60 |
5 |
BASF SE | 19740 |
4 |
Other owners | 389 |